On August 31, 2023 UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, reported that it will present at the following investor conferences in September (Press release, UroGen Pharma, AUG 31, 2023, View Source [SID1234634808]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 25th Annual Global Investment Conference — September 11-13, 2023

Presentation: Tuesday, September 12th at 10:00 AM ET
Webcast Link: View Source

2023 Cantor Fitzgerald Global Healthcare Conference — September 26 – 28, 2023

Fireside Chat: Tuesday, September 26th at 8:35 AM ET
Webcast Link: View Source
Webcasts for both conferences will be available via the Investors section of UroGen’s website, www.urogen.com. A replay of each webcast will be available on the Company’s website for approximately 90 days.